Clinical Trial Update: An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder [NA]

View source ↗

Summary

Open-label trial investigating memantine for bulimia nervosa and body dysmorphic disorder. The study is completed and results were posted on 2012-06-12.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Body Dysmorphic Disorder
• Bulimia Nervosa

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Mclean Hospital | Conditions: Bulimia Nervosa, Body Dysmorphic Disorder | NA | Status: COMPLETED | Results posted: 2012-06-12